Complicated Thoracic Empyema of Serotype 23F Streptococcus pneumoniae in an Adult Patient
Keywords:
pulmonology, infection, Streptococcus pneumonia, Thoracic empyema, adult patient, Serotype 23FAbstract
We report a case of thoracic empyema in a 61-year-old male patient, a heavy smoker with malignancy undergoing chemotherapy. The patient’s clinical symptoms included shortness of breath, productive cough, fever, and chest pain. This patient had never received antibiotics before. Streptococcus pneumoniae was isolated from a bedside culture of empyema fluid collected through thoracentesis. The empyema fluid was cultured on chocolate agar plates and in aerobic and anaerobic culture bottles. The isolate was identified as serotype 23F, a vaccine strain with sequence type 17532. The isolate was resistant to chloramphenicol, tetracycline, and cotrimoxazole. The patient clinically improved with the administration of combined intravenous ceftriaxone and levofloxacin antibiotics, along with chest tube drainage via thoracostomy. This is the first report of thoracic empyema caused by S. pneumoniae in an adult in Indonesia. Serotype 23F is multi-resistant with low invasiveness, typically causing infections in patients with underlying health conditions. The pneumococcal conjugate vaccine covers it; thus, it usually occurs in areas with low vaccine coverage. Our findings support the importance of improving adult pneumococcal vaccination coverage in Indonesia.References
Ikuta KS, Swetschinski LR, Robles Aguilar G, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022 Dec;400(10369):2221–48.
Whitney CG. Pneumococcal and haemophilus influenzae type b disease: moving numbers in the right direction. Lancet Glob Health. 2018 Jul;6(7):e706–7.
O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet. 2009 Sep;374(9693):893–902.
Kartasasmita CB, Rezeki Hadinegoro S, Kurniati N, Triasih R, Halim C, Gamil A. Epidemiology, nasopharyngeal carriage, serotype prevalence, and antibiotic resistance of Streptococcus pneumoniae in Indonesia. Infect Dis Ther. 2020 Dec;9(4):723–36.
Farida H, Severin JA, Gasem MH, et al. Nasopharyngeal carriage of Streptococcus pneumonia in pneumonia-prone age groups in Semarang, Java Island, Indonesia. Chabalgoity JA, editor. PLoS ONE. 2014 Jan 31;9(1):e87431.
Hung IFN, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013 Jun;17(6):e364–73.
Farida H, Gasem MH, Suryanto A, et al. Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study. Int J Infect Dis. 2015 Sep;38:101–7.
Amanda G, Tafroji W, Sutoyo DK, Burhan E, Haryanto B, Safari D. Serotype distribution and antimicrobial profile of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Jakarta, Indonesia. J Microbiol Immunol Infect. 2021 Dec;54(6):1175–8.
Barnes DM. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: Evidence suggesting capsular transformation of the resistant strain in vivo. The Journal of Infectious Diseases. 1995. Available at: https://pubmed.ncbi.nlm.nih.gov/7706816
Muñoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae [Internet]. U.S. National Library of Medicine; 1991. Available from: https://pubmed.ncbi.nlm.nih.gov/1856478/
Schwengers O, Hain T, Chakraborty T, Goesmann A. ReferenceSeeker: rapid determination of appropriate reference genomes. J Open Source Softw. 2020 Feb 4;5(46):1994.
Fletcher MA, Schmitt HJ, Syrochkina M, Sylvester G. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):879–910.
Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011 Aug 1;66(8):658–62.
Said WF, Sukoto E, Khoeri MM, Kumalawati J, Safari D. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from adult patients in Jakarta, Indonesia. J Infect Public Health. 2017 Nov;10(6):833–5.
Grau I, Ardanuy C, Calatayud L, et al. Invasive pneumococcal disease in healthy adults: Increase of empyema associated with the clonal-type Sweden1-ST306. In: Borrow R, editor. PLoS ONE. 2012 Aug 13;7(8):e42595.
Salahuddin M, Ost D, Hwang H, et al. Clinical risk factors for death in patients with empyema and active malignancy. Cureus [Internet]. 2023 Apr 13 [cited 2024 Feb 16]; Available from: https://www.cureus.com/articles/149124-clinical-risk-factors-for-death-in-patients-with-empyema-and-active-malignancy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indra Yovi, Aisyah Elliyanti, Dodi Safari, Nur Afrainin, Dewi Anggraini, Rosantia Sarassari, Yustinus Maladan, Ayummi Azzahrah, Nicholas Gilbert Pelawi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
